Jing-Yan Han

Peking University

Papers

1

Total Citations

1,480

H-Index

1

About

Jing-Yan Han is a pioneering researcher at the intersection of DNA nanotechnology and biomedicine, best known for her groundbreaking work in developing DNA-based nanorobots for targeted cancer therapy. Her most cited paper, "A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo" (2018), has garnered over 1,480 citations, marking a transformative advance in the field. In this study, Han and her team engineered a DNA nanorobot that navigates the bloodstream, recognizes a molecular trigger specific to tumor microenvironments, and delivers a therapeutic payload directly to cancer cells, minimizing off-target effects. This work demonstrated the first in vivo application of a DNA nanorobot for cancer treatment, opening new avenues for precision medicine. Beyond this flagship achievement, Han’s research spans the design of dynamic DNA nanostructures, logic-gated drug delivery systems, and biomolecular computing. Her contributions have been recognized with multiple awards and invitations to speak at international conferences, solidifying her reputation as a leader in DNA nanotechnology. For students and researchers, Han’s work exemplifies how interdisciplinary approaches—merging engineering, biology, and chemistry—can solve complex medical challenges.

Research Focus

Key Achievements

1
H-Index
1
Papers
1,480
Total Citations
1,480
Avg Citations/Paper
🏆 Most Cited Paper
A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo
1,480 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Peking University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago